Syneron Medical Ltd (ELOS) Tops Q1 Estimates
Tweet Send to a FriendGet Alerts ELOS Hot Sheet
Trade ELOS Now!
Syneron Medical Ltd (NASDAQ: ELOS) reported Q1 EPS of ($0.07), $0.08 better than the analyst estimate of ($0.15). For Q1, Non-GAAP net income per share attributable to Syneron shareholders operations before non-controlling interest came out to $0.02 profit.
Revenue for the quarter came in at $62.66 million versus the consensus estimate of $55.91 million.
For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Revenue for the quarter came in at $62.66 million versus the consensus estimate of $55.91 million.
For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
- Brady Corp. (BRC) Misses Q3 EPS by 5c; Guides Q4 EPS Below Views
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
